Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits
Abstract
Share and Cite
Corey, A.; Migone, T.-S.; Bolmer, S.; Fiscella, M.; Ward, C.; Chen, C.; Meister, G. Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits. Toxins 2013, 5, 120-138. https://doi.org/10.3390/toxins5010120
Corey A, Migone T-S, Bolmer S, Fiscella M, Ward C, Chen C, Meister G. Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits. Toxins. 2013; 5(1):120-138. https://doi.org/10.3390/toxins5010120
Chicago/Turabian StyleCorey, Alfred, Thi-Sau Migone, Sally Bolmer, Michele Fiscella, Chris Ward, Cecil Chen, and Gabriel Meister. 2013. "Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits" Toxins 5, no. 1: 120-138. https://doi.org/10.3390/toxins5010120
APA StyleCorey, A., Migone, T.-S., Bolmer, S., Fiscella, M., Ward, C., Chen, C., & Meister, G. (2013). Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits. Toxins, 5(1), 120-138. https://doi.org/10.3390/toxins5010120